Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
PHASE2CompletedINTERVENTIONAL
Enrollment
49
Participants
Timeline
Start Date
January 22, 2016
Primary Completion Date
December 4, 2017
Study Completion Date
December 30, 2018
Conditions
Ocular Surface Disease
Interventions
DRUG
GL101
Topical Gel
DRUG
Placebo
Placebo topical gel
Trial Locations (1)
10003
New York Eye & Ear Infirmary of Mount Sinai, New York
All Listed Sponsors
lead
Glia, LLC
INDUSTRY
NCT02656394 - Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 | Biotech Hunter | Biotech Hunter